Skip to main content
Erschienen in: Pediatric Cardiology 8/2023

10.08.2023 | Research

Chylothorax After Heart Surgery in Children

verfasst von: Juliane Kuster Bauer, Nathalia Hocama, Anna Clara Traub, Gabriel Rutes, Mariana Millan Fachi, Janaina Moraes, Andrea Lenzi, Heloisa Arruda Gomm Barreto

Erschienen in: Pediatric Cardiology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Chylothorax is a consequence of a thoracic duct injury that can occur during surgical procedures in patients with congenital heart disease. It is associated with high rates of morbimortality and increased use of clinical and hospital resources. The aim of this study was to evaluate the risk factors, distribution, manifestations, complications, and treatments for chylothorax in patients undergoing cardiac surgery in a tertiary pediatric hospital in southern Brazil. This is a retrospective, quantitative study, in which all medical records (n = 166) of patients with chylothorax after pediatric cardiac surgery between January 2014 and December of 2020 and a matched control group (n = 166) were analyzed. Over the study period, there was an increase in incidence of chylothorax from 4.5% in 2014 to 7.6% in 2020, a trend that has been reported in the literature. After multivariate analysis, the following were identified as risk factors for the diagnosis of chylothorax: genetic syndrome (OR 2.298); prolonged cardiopulmonary bypass time (greater than 120 min) (OR 2.410); fluid overload in the immediate postoperative period (OR 1.110); and SIRS (OR 2.527). Mortality was two times greater (p = 0.021) and there was a higher rate (34.4%) of infection (p < 0.001) in patients who developed chylothorax. In addition, a sensitivity analysis was performed comparing patients with low- and high-output chylothorax (> 20 mL/kg), which confirmed unfavorable outcomes for the latter group. Herein, we show that hemodynamic alterations were important factors for diagnosis. Understanding the risk factors, outcomes, and complications helps early identification and enables the reduction of morbidity and mortality.
Literatur
2.
Zurück zum Zitat Ahmed MA, Sr (2021) Post-operative Chylothorax in Children undergoing congenital heart surgery. Cureus 13(3):e13811. https://doi.org/10.7759%2Fcureus.13811PubMedPubMedCentral Ahmed MA, Sr (2021) Post-operative Chylothorax in Children undergoing congenital heart surgery. Cureus 13(3):e13811. https://​doi.​org/​10.​7759%2Fcureus.13811PubMedPubMedCentral
4.
Zurück zum Zitat Yakuwa K, Miyaji K, Kitamura T, Miyamoto T, Ono M, Kaneko Y (2021) Neutrophil-to-lymphocyte ratio is prognostic factor of prolonged pleural effusion after pediatric cardiac surgery. JRSM Cardiovasc disease 10:20480040211009438. https://doi.org/10.1177%2F20480040211009438CrossRef Yakuwa K, Miyaji K, Kitamura T, Miyamoto T, Ono M, Kaneko Y (2021) Neutrophil-to-lymphocyte ratio is prognostic factor of prolonged pleural effusion after pediatric cardiac surgery. JRSM Cardiovasc disease 10:20480040211009438. https://​doi.​org/​10.​1177%2F20480040211009438CrossRef
5.
Zurück zum Zitat Akbari Asbagh P, Navabi Shirazi MA, Soleimani A, Razzaz M, Akbari Asbagh N, Rayatzadeh H et al (2014) Incidence and etiology of chylothorax after congenital heart surgery in children. J Tehran Heart Cent 9(2):59–63PubMedPubMedCentral Akbari Asbagh P, Navabi Shirazi MA, Soleimani A, Razzaz M, Akbari Asbagh N, Rayatzadeh H et al (2014) Incidence and etiology of chylothorax after congenital heart surgery in children. J Tehran Heart Cent 9(2):59–63PubMedPubMedCentral
8.
Zurück zum Zitat Cacciaguerra S, Catalano P, Antonelli E, Arena S (2019) Pneumothorax and Chylothorax. In: Lima M, Reinberg O (eds) Neonatal surgery: contemporary strategies from fetal life to the First Year of Age. Springer International Publishing, Cham, pp 151–166CrossRef Cacciaguerra S, Catalano P, Antonelli E, Arena S (2019) Pneumothorax and Chylothorax. In: Lima M, Reinberg O (eds) Neonatal surgery: contemporary strategies from fetal life to the First Year of Age. Springer International Publishing, Cham, pp 151–166CrossRef
9.
Zurück zum Zitat Rudrappa M, Paul M (2022) Chylothorax. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022. StatPearls Publishing LLC. Rudrappa M, Paul M (2022) Chylothorax. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022. StatPearls Publishing LLC.
10.
Zurück zum Zitat Shin YR, Lee H, Park YH, Park HK (2020) Chylothorax after surgery for congenital Cardiac Disease: a Prevention and Management Protocol. Korean J Thorac Cardiovasc Surg 53(2):41–48. https://doi.org/10.5090%2Fkjtcs.2020.53.2.41CrossRefPubMedPubMedCentral Shin YR, Lee H, Park YH, Park HK (2020) Chylothorax after surgery for congenital Cardiac Disease: a Prevention and Management Protocol. Korean J Thorac Cardiovasc Surg 53(2):41–48. https://​doi.​org/​10.​5090%2Fkjtcs.2020.53.2.41CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Ismail SR, Kabbani MS, Najm HK, Shaath GA, Jijeh AM, Hijazi OM (2014) Impact of chylothorax on the early post operative outcome after pediatric cardiovascular surgery. J Saudi Heart Association 26(2):87–92. https://doi.org/10.1016%2Fj.jsha.2014.01.001CrossRefPubMedPubMedCentral Ismail SR, Kabbani MS, Najm HK, Shaath GA, Jijeh AM, Hijazi OM (2014) Impact of chylothorax on the early post operative outcome after pediatric cardiovascular surgery. J Saudi Heart Association 26(2):87–92. https://​doi.​org/​10.​1016%2Fj.jsha.2014.01.001CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Czobor NR, Roth G, Prodán Z, Lex DJ, Sápi E, Ablonczy L et al (2017) Chylothorax after pediatric cardiac surgery complicates short-term but not long-term outcomes-a propensity matched analysis. J Thorac disease 9(8):2466–2475. https://doi.org/10.21037%2Fjtd.2017.07.88CrossRef Czobor NR, Roth G, Prodán Z, Lex DJ, Sápi E, Ablonczy L et al (2017) Chylothorax after pediatric cardiac surgery complicates short-term but not long-term outcomes-a propensity matched analysis. J Thorac disease 9(8):2466–2475. https://​doi.​org/​10.​21037%2Fjtd.2017.07.88CrossRef
24.
26.
Zurück zum Zitat Guo Y, Chen J, Xu B, Zheng Y, Shen K (2018) Causes and manifestations of chylothorax in children in China: experience from a children’s medical center, 2007–2017. Pediatr Invest 2(1):8–14. https://doi.org/10.1002%2Fped4.12019CrossRef Guo Y, Chen J, Xu B, Zheng Y, Shen K (2018) Causes and manifestations of chylothorax in children in China: experience from a children’s medical center, 2007–2017. Pediatr Invest 2(1):8–14. https://​doi.​org/​10.​1002%2Fped4.12019CrossRef
29.
Zurück zum Zitat Hoskote AU, Ramaiah RN, Cale CM, Hartley JC, Brown KL (2012) Role of immunoglobulin supplementation for secondary immunodeficiency associated with chylothorax after pediatric cardiothoracic surgery. Pediatric critical care medicine: a journal of the society of critical Care Medicine and the World Federation of Pediatric Intensive and. Crit Care Soc 13(5):535–541. https://doi.org/10.1097/pcc.0b013e318241793dCrossRef Hoskote AU, Ramaiah RN, Cale CM, Hartley JC, Brown KL (2012) Role of immunoglobulin supplementation for secondary immunodeficiency associated with chylothorax after pediatric cardiothoracic surgery. Pediatric critical care medicine: a journal of the society of critical Care Medicine and the World Federation of Pediatric Intensive and. Crit Care Soc 13(5):535–541. https://​doi.​org/​10.​1097/​pcc.​0b013e318241793d​CrossRef
Metadaten
Titel
Chylothorax After Heart Surgery in Children
verfasst von
Juliane Kuster Bauer
Nathalia Hocama
Anna Clara Traub
Gabriel Rutes
Mariana Millan Fachi
Janaina Moraes
Andrea Lenzi
Heloisa Arruda Gomm Barreto
Publikationsdatum
10.08.2023
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2023
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-023-03250-6

Weitere Artikel der Ausgabe 8/2023

Pediatric Cardiology 8/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.